---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008417"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T22:47:44.544215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma reduces quorum threshold, adds change-in-control bonuses for CEO/CFO, schedules annual meeting

## Summary
- Board reduced stockholder quorum from majority to one-third of voting power to facilitate meetings.
- CEO Jerome Jabbour eligible for retention bonus up to $299,000 if change in control occurs before March 31, 2026.
- CFO Keith Kucinski eligible for retention bonus up to $166,400 under same change-in-control terms.
- 2025 annual meeting set for June 23, 2025; record date May 1, 2025.
- Stockholder proposals and nominations must be received by May 12, 2025.

## SEC filing metadata
- accession: 0001641172-25-008417
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.02, 5.08, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000164117225008417/0001641172-25-008417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000164117225008417/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008417
- JSON: https://secwatch.observer/filing/0001641172-25-008417.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.